kyorin holdings inc
(4569:Tokyo Stock Exchange)
John W. Kozarich Ph.D.
|Age||Total Calculated Compensation||This person is connected to 63 board members in 8 different organizations across 11 different industries.|
See Board Relationships
Dr. John W. Kozarich, Ph.D., has been an Advisor of Corium International, Inc. since April 1, 2015. Dr. Kozarich served as the Chief Scientific Advisor of KYORIN Holdings, Inc. since February 2005. He served as the Chairman and President at ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Holdings and KYORIN Pharmaceutical Co., Ltd. since February 2005. He also served as Scientific Advisor at Ligand Pharmaceuticals Incorporated. He joined ActivX Biosciences ...
6, Kanda Surugadai 4-chomePhone: 81 3 3525 4700
Tokyo, -- 101-8311
Board Members Memberships*
Chairman and President
Chairman and Member of Nominating & Corporate Governance Committee
Independent Director and Chairman of Scientific Review Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Chairman of the Board
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|Vincent A. Forlenza||Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Becton, Dickinson and Company
|Heather Bresch||Chief Executive Officer, Executive Director and Member of Science & Technology Committee|
|Hirotaka Nakatomi||Chairman, Chief Executive Officer and Chairman of Crisis Management Committee|
Hisamitsu Pharmaceutical Co., Inc.
|Stephen J. Farr Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
|Konstantinos Alataris Ph.D.||Chief Executive Officer, President and Director|
Zosano Pharma Corporation
|$105.3K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.